NCT03038932View on ClinicalTrials.gov

Etiology of Eczema Herpeticum (EH)

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Eczema Herpeticum
Trial Locations (1)

80206

National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, Denver

All Listed Sponsors
collaborator

Atopic Dermatitis Research Network

OTHER

collaborator

Rho Federal Systems Division, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03038932 - Etiology of Eczema Herpeticum (EH) | Biotech Hunter | Biotech Hunter